Neuroactive steroid solutions and their methods of use
AssigneeSage Therapeutics, Inc.
InventorsFrancesco G. Salituro, Albert J. Robichaud, Paul Steven Watson, William Hunke
Life of this patent
Estimating the term…
Loading patent…
AssigneeSage Therapeutics, Inc.
InventorsFrancesco G. Salituro, Albert J. Robichaud, Paul Steven Watson, William Hunke
Estimating the term…
Provided herein are pharmaceutically acceptable aqueous solution comprising a neuroactive steroid, a sulfobutyl ether beta cyclodextrin and a buffer; wherein: the solution is a stable solution between a pH of about 3 and about 9, e.g., at room temperature, for at least 1, 2, 3, 4 weeks; 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 months; 1, 2, 3 years or more; the buffer is present at a concentration of at least 0.1 mM; or the solution remains substantially free of impurities (e.g., the solution is substantially free of impurities at room temperature for at least 1, 2, 3, 4 weeks; 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 months; 1, 2, 3 years or more).
A pharmaceutically acceptable aqueous solution comprising (e.g., consisting essentially of, consisting of) a neuroactive steroid, a sulfobutyl ether beta cyclodextrin and a buffer;
2-84. (canceled)
Dependencies are inferred from the claim text.